{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T08:19:33Z","timestamp":1778660373150,"version":"3.51.4"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"United States Food and Drug Administration internally"},{"DOI":"10.13039\/100005196","name":"Bureau of Justice Assistance","doi-asserted-by":"publisher","award":["2011-D6-BX-K052"],"award-info":[{"award-number":["2011-D6-BX-K052"]}],"id":[{"id":"10.13039\/100005196","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Institute for Behavioral Health at Brandeis University"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.drugalcdep.2018.02.019","type":"journal-article","created":{"date-parts":[[2018,4,10]],"date-time":"2018-04-10T12:24:40Z","timestamp":1523363080000},"page":"221-226","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Concomitant use of buprenorphine for medication-assisted treatment of opioid use disorder and benzodiazepines: Using the prescription behavior surveillance system"],"prefix":"10.1016","volume":"187","author":[{"given":"Yanmin","family":"Zhu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. Tyler","family":"Coyle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Mohamoud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esther","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Efe","family":"Eworuke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Dormitzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judy","family":"Staffa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2018.02.019_bib0005","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1526-4637.2011.01075.x","article-title":"Societal costs of prescription opioid abuse, dependence, and misuse in the United States","volume":"12","author":"Birnbaum","year":"2011","journal-title":"Pain Med."},{"key":"10.1016\/j.drugalcdep.2018.02.019_bib0010","series-title":"The Heller School for Social Policy and Management. Prescription Drug Monitoring Program Center of Excellence Frequently Asked Questions","author":"Brandeis University","year":"2017"},{"key":"10.1016\/j.drugalcdep.2018.02.019_bib0015","series-title":"Vital Signs: Prescription Painkiller Overdoses in the US","author":"enter for Disease Control (CDC)","year":"2011"},{"key":"10.1016\/j.drugalcdep.2018.02.019_bib0020","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jpain.2008.10.008","article-title":"Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain","volume":"10","author":"Chou","year":"2009","journal-title":"J. Pain"},{"key":"10.1016\/j.drugalcdep.2018.02.019_bib0025","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/HRP.0000000000000075","article-title":"Medication-assisted treatment of opioid use disorder: review of the evidence and future directions","volume":"23","author":"Connery","year":"2015","journal-title":"Harvard Rev. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2018.02.019_bib0030","first-page":"1","article-title":"CDC guideline for prescribing opioids for chronic pain \u2013 United States, 2016","volume":"65","author":"Dowell","year":"2016","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.drugalcdep.2018.02.019_bib0035","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1111\/j.1365-2044.1983.tb12045.x","article-title":"Buprenorphine, benzodiazepines and respiratory depression","volume":"38","author":"Faroqui","year":"1983","journal-title":"Anaesthesia"},{"key":"10.1016\/j.drugalcdep.2018.02.019_bib0040","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1056\/NEJMoa055255","article-title":"Counseling plus buprenorphine-naloxone maintenance therapy for opioid dependence","volume":"355","author":"Fiellin","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drugalcdep.2018.02.019_bib0045","first-page":"481","article-title":"Prescription drug monitoring programs","volume":"10","author":"Finklea","year":"2014","journal-title":"J. Drug Addict. Educ. Erad."},{"key":"10.1016\/j.drugalcdep.2018.02.019_bib0050","series-title":"Drug Safety Communication: FDA Urges Caution About Withholding Opioid Addiction Medications from Patients Taking Benzodiazepines or CNS Depressants: Careful Medication Management can Reduce Risks","author":"Food and Drug Administration (FDA)","year":"2016"},{"key":"10.1016\/j.drugalcdep.2018.02.019_bib0055","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1056\/NEJMoa022164","article-title":"Buprenorphine\/Naloxone Collaborative Study, G.,. Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone","volume":"349","author":"Fudala","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drugalcdep.2018.02.019_bib0060","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1001\/archinternmed.2011.117","article-title":"Opioid dose and drug-related mortality in patients with nonmalignant pain","volume":"171","author":"Gomes","year":"2011","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.drugalcdep.2018.02.019_bib0065","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1001\/jama.2011.1712","article-title":"Can prescription drug monitoring programs help limit opioid abuse?","volume":"306","author":"Gugelmann","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.drugalcdep.2018.02.019_bib0070","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1001\/jama.2014.18514","article-title":"Mandatory use of prescription drug monitoring programs","volume":"313","author":"Haffajee","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.drugalcdep.2018.02.019_bib0075","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00228-011-1122-4","article-title":"Benzodiazepines and alcohol are associated with cases of fatal buprenorphine poisoning","volume":"68","author":"Hakkinen","year":"2012","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2018.02.019_bib0080","series-title":"Behavioral Health Trends in the United States: Results from the 2014 National Survey on Drug Use and Health","author":"Hedden","year":"2015"},{"key":"10.1016\/j.drugalcdep.2018.02.019_bib0085","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.amepre.2016.02.014","article-title":"Trends in the concomitant prescribing of opioids and benzodiazepines, 2002\u20132014","volume":"51","author":"Hwang","year":"2016","journal-title":"Am. J. Prev. Med."},{"key":"10.1016\/j.drugalcdep.2018.02.019_bib0090","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.amepre.2015.03.040","article-title":"Emergency department visits and overdose deaths from combined use of opioids and benzodiazepines","volume":"49","author":"Jones","year":"2015","journal-title":"Am. J. Prev. Med."},{"key":"10.1016\/j.drugalcdep.2018.02.019_bib0095","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.drugalcdep.2012.07.004","article-title":"Polydrug abuse: a review of opioid and benzodiazepine combination use","volume":"125","author":"Jones","year":"2012","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2018.02.019_bib0100","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/ADM.0000000000000166","article-title":"American Society of Addiction Medicine (ASAM) national practice guideline for the use of medications in the treatment of addiction involving opioid use","volume":"9","author":"Kampman","year":"2015","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.drugalcdep.2018.02.019_bib0105","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.ajem.2016.11.054","article-title":"Benzodiazepine-opioid co-prescribing in a national probability sample of emergency department encounters","volume":"35","author":"Kim","year":"2016","journal-title":"Am. J. Emerg. Med."},{"key":"10.1016\/j.drugalcdep.2018.02.019_bib0110","doi-asserted-by":"crossref","first-page":"644","DOI":"10.15288\/jsad.2015.76.644","article-title":"The supply of physicians waivered to prescribe buprenorphine for opioid use disorders in the United States: a state-level analysis","volume":"76","author":"Knudsen","year":"2015","journal-title":"J. Stud. Alcohol Drugs"},{"key":"10.1016\/j.drugalcdep.2018.02.019_bib0115","series-title":"Prescription Behavior Surveillance System Data","author":"Kreiner","year":"2017"},{"key":"10.1016\/j.drugalcdep.2018.02.019_bib0120","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1002\/pds.3776","article-title":"Trends in opioid prescribing and co-prescribing of sedative hypnotics for acute and chronic musculoskeletal pain: 2001\u20132010","volume":"24","author":"Larochelle","year":"2015","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.drugalcdep.2018.02.019_bib0125","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1521-0391.2009.00007.x","article-title":"Benzodiazepines, methadone and buprenorphine: interactions and clinical management","volume":"19","author":"Lintzeris","year":"2010","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.drugalcdep.2018.02.019_bib0130","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.drugalcdep.2007.05.019","article-title":"Pharmacodynamics of diazepam co-administered with methadone or buprenorphine under high dose conditions in opioid dependent patients","volume":"91","author":"Lintzeris","year":"2007","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2018.02.019_bib0135","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3109\/15360288.2012.738288","article-title":"The use of prescription monitoring programs to reduce opioid diversion and improve patient safety","volume":"27","author":"Morgan","year":"2013","journal-title":"J. Pain Palliat. Care Pharmacother."},{"key":"10.1016\/j.drugalcdep.2018.02.019_bib0140","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/j.1360-0443.2006.01731.x","article-title":"Concurrent buprenorphine and benzodiazepines use and self-reported opioid toxicity in opioid substitution treatment","volume":"102","author":"Nielsen","year":"2007","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2018.02.019_bib0145","series-title":"Clinical Guidelines for the Use of Benzodiazepines Among Patients Receiving Medication Assisted Treatment for Opioid Dependence","author":"Olsen","year":"2013"},{"key":"10.1016\/j.drugalcdep.2018.02.019_bib0150","doi-asserted-by":"crossref","DOI":"10.1176\/appi.ps.201300419","article-title":"Datapoints: regional variation in benzodiazepine prescribing for patients on opioid agonist therapy","volume":"65","author":"Park","year":"2014","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.drugalcdep.2018.02.019_bib0155","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1377\/hlthaff.2015.1496","article-title":"Implementation of prescription drug monitoring programs associated with reductions in opioid-related death rates","volume":"35","author":"Patrick","year":"2016","journal-title":"Health Aff."},{"key":"10.1016\/j.drugalcdep.2018.02.019_bib0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.ss6409a1","article-title":"Centers for Disease Control and Prevention, 2015. Controlled substance prescribing patterns\u2014Prescription behavior surveillance system, eight states","volume":"64","author":"Paulozzi","year":"2013","journal-title":"MMWR Surveill. Summ."},{"key":"10.1016\/j.drugalcdep.2018.02.019_bib0165","first-page":"563","article-title":"Vital signs: variation among states in prescribing of opioid pain relievers and benzodiazepines\u2014 United States, 2012","volume":"63","author":"Paulozzi","year":"2014","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.drugalcdep.2018.02.019_bib0170","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1097\/MLR.0b013e31824ebd81","article-title":"Doctor and pharmacy shopping for controlled substances","volume":"50","author":"Peirce","year":"2012","journal-title":"Med. Care"},{"key":"10.1016\/j.drugalcdep.2018.02.019_bib0175","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/j.1526-4637.2012.01327.x","article-title":"Do prescription monitoring programs impact state trends in opioid abuse\/misuse?","volume":"13","author":"Reifler","year":"2012","journal-title":"Pain Med."},{"key":"10.1016\/j.drugalcdep.2018.02.019_bib0180","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.15585\/mmwr.mm655051e1","article-title":"Increases in drug and opioid-involved overdose deaths \u2013 United States: 2010\u20132015","volume":"65","author":"Rudd","year":"2016","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.drugalcdep.2018.02.019_bib0185","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.drugalcdep.2013.04.006","article-title":"Benzodiazepine use during buprenorphine treatment for opioid dependence: clinical and safety outcomes","volume":"132","author":"Schuman-Olivier","year":"2013","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2018.02.019_bib0190","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jsat.2014.07.010","article-title":"Supply of buprenorphine waivered physicians: the influence of state policies","volume":"48","author":"Stein","year":"2015","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2018.02.019_bib0195","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1056\/NEJMp1402780","article-title":"Medication-assisted therapies\u2014tackling the opioid-overdose epidemic","volume":"370","author":"Volkow","year":"2014","journal-title":"N. Engl. J. Med."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871618301819?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871618301819?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,2,24]],"date-time":"2020-02-24T12:22:47Z","timestamp":1582546967000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871618301819"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":39,"alternative-id":["S0376871618301819"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2018.02.019","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Concomitant use of buprenorphine for medication-assisted treatment of opioid use disorder and benzodiazepines: Using the prescription behavior surveillance system","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2018.02.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}